Jobs Jetty helps you send them a short, personal note from your own resume.
Raised Series B ($110M), Aug 2021
T-knife Therapeutics develops T cell receptor engineered T cell therapies for patients with solid tumors; its lead candidate TK-6302 targets PRAME.
Research · 55 people · San Francisco, United States
Join to see who to write to, then send them a note in your own words.
Join Jobs Jetty